vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and Crane NXT, Co. (CXT). Click either name above to swap in a different company.

Crane NXT, Co. is the larger business by last-quarter revenue ($476.9M vs $292.2M, roughly 1.6× Cellebrite DI Ltd.). Crane NXT, Co. runs the higher net margin — 10.0% vs -103.5%, a 113.4% gap on every dollar of revenue. Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs 23.3%).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

Crane Co. is an American industrial products company based in Stamford, Connecticut. Founded by Richard Teller Crane in 1855, it became one of the leading manufacturers of bathroom fixtures in the United States, until 1990, when that division was sold off. In 1960 it began the process of becoming a holding company with a diverse portfolio. Its business segments are Aerospace & Electronics, Engineered Materials, Fluid Handling, and Controls. Industries served by these segments include chemical...

CLBT vs CXT — Head-to-Head

Bigger by revenue
CXT
CXT
1.6× larger
CXT
$476.9M
$292.2M
CLBT
Higher net margin
CXT
CXT
113.4% more per $
CXT
10.0%
-103.5%
CLBT
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
23.3%
CXT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CLBT
CLBT
CXT
CXT
Revenue
$292.2M
$476.9M
Net Profit
$-302.3M
$47.5M
Gross Margin
84.6%
42.4%
Operating Margin
14.1%
16.7%
Net Margin
-103.5%
10.0%
Revenue YoY
19.5%
Net Profit YoY
EPS (diluted)
$-1.50
$0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
CXT
CXT
Q4 25
$476.9M
Q3 25
$292.2M
$445.1M
Q2 25
$220.8M
$404.4M
Q1 25
$89.6M
$330.3M
Q4 24
$399.1M
Q3 24
$232.1M
$403.5M
Q2 24
$185.3M
$370.6M
Q1 24
$71.2M
$313.6M
Net Profit
CLBT
CLBT
CXT
CXT
Q4 25
$47.5M
Q3 25
$-302.3M
$50.5M
Q2 25
$36.9M
$24.9M
Q1 25
$-71.4M
$21.7M
Q4 24
Q3 24
$47.1M
Q2 24
$-95.2M
$41.6M
Q1 24
$-40.6M
$37.8M
Gross Margin
CLBT
CLBT
CXT
CXT
Q4 25
42.4%
Q3 25
84.6%
43.3%
Q2 25
84.1%
41.7%
Q1 25
85.2%
42.4%
Q4 24
45.2%
Q3 24
83.5%
42.5%
Q2 24
84.1%
43.4%
Q1 24
82.6%
48.6%
Operating Margin
CLBT
CLBT
CXT
CXT
Q4 25
16.7%
Q3 25
14.1%
18.4%
Q2 25
12.1%
11.8%
Q1 25
10.3%
11.3%
Q4 24
17.7%
Q3 24
7.9%
18.6%
Q2 24
11.7%
18.2%
Q1 24
0.2%
17.7%
Net Margin
CLBT
CLBT
CXT
CXT
Q4 25
10.0%
Q3 25
-103.5%
11.3%
Q2 25
16.7%
6.2%
Q1 25
-79.7%
6.6%
Q4 24
Q3 24
11.7%
Q2 24
-51.4%
11.2%
Q1 24
-57.0%
12.1%
EPS (diluted)
CLBT
CLBT
CXT
CXT
Q4 25
$0.82
Q3 25
$-1.50
$0.87
Q2 25
$0.15
$0.43
Q1 25
$-0.36
$0.38
Q4 24
$1.00
Q3 24
$-0.35
$0.81
Q2 24
$-0.48
$0.72
Q1 24
$-0.21
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
CXT
CXT
Cash + ST InvestmentsLiquidity on hand
$191.7M
$233.8M
Total DebtLower is stronger
$1.0B
Stockholders' EquityBook value
$336.0M
$1.3B
Total Assets
$690.6M
$3.1B
Debt / EquityLower = less leverage
0.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
CXT
CXT
Q4 25
$233.8M
Q3 25
$191.7M
$182.4M
Q2 25
$326.1M
$152.5M
Q1 25
$191.7M
$173.8M
Q4 24
$165.8M
Q3 24
$189.5M
$165.1M
Q2 24
$178.6M
$175.5M
Q1 24
$189.5M
$220.6M
Total Debt
CLBT
CLBT
CXT
CXT
Q4 25
$1.0B
Q3 25
$834.3M
Q2 25
$861.8M
Q1 25
$541.1M
Q4 24
$540.6M
Q3 24
$638.2M
Q2 24
$638.9M
Q1 24
$639.6M
Stockholders' Equity
CLBT
CLBT
CXT
CXT
Q4 25
$1.3B
Q3 25
$336.0M
$1.2B
Q2 25
$408.4M
$1.2B
Q1 25
$336.0M
$1.1B
Q4 24
$1.1B
Q3 24
$34.2M
$1.1B
Q2 24
$-40.2M
$989.8M
Q1 24
$34.2M
$964.1M
Total Assets
CLBT
CLBT
CXT
CXT
Q4 25
$3.1B
Q3 25
$690.6M
$2.9B
Q2 25
$787.4M
$2.9B
Q1 25
$690.6M
$2.4B
Q4 24
$2.4B
Q3 24
$532.9M
$2.4B
Q2 24
$556.6M
$2.4B
Q1 24
$532.9M
$2.1B
Debt / Equity
CLBT
CLBT
CXT
CXT
Q4 25
0.80×
Q3 25
0.69×
Q2 25
0.73×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.60×
Q2 24
0.65×
Q1 24
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
CXT
CXT
Operating Cash FlowLast quarter
$66.2M
$105.8M
Free Cash FlowOCF − Capex
$60.8M
FCF MarginFCF / Revenue
20.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
2.23×
TTM Free Cash FlowTrailing 4 quarters
$172.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
CXT
CXT
Q4 25
$105.8M
Q3 25
$66.2M
$92.0M
Q2 25
$53.5M
$62.8M
Q1 25
$10.0M
$-19.1M
Q4 24
$81.1M
Q3 24
$58.2M
$66.7M
Q2 24
$24.6M
$56.8M
Q1 24
$12.5M
$9.5M
Free Cash Flow
CLBT
CLBT
CXT
CXT
Q4 25
Q3 25
$60.8M
$78.7M
Q2 25
$47.5M
$55.8M
Q1 25
$8.5M
$-32.2M
Q4 24
Q3 24
$55.3M
$53.5M
Q2 24
$21.0M
$47.9M
Q1 24
$11.4M
$-3.0M
FCF Margin
CLBT
CLBT
CXT
CXT
Q4 25
Q3 25
20.8%
17.7%
Q2 25
21.5%
13.8%
Q1 25
9.5%
-9.7%
Q4 24
Q3 24
23.8%
13.3%
Q2 24
11.3%
12.9%
Q1 24
16.0%
-1.0%
Capex Intensity
CLBT
CLBT
CXT
CXT
Q4 25
Q3 25
1.8%
3.0%
Q2 25
2.7%
1.7%
Q1 25
1.7%
4.0%
Q4 24
Q3 24
1.3%
3.3%
Q2 24
1.9%
2.4%
Q1 24
1.5%
4.0%
Cash Conversion
CLBT
CLBT
CXT
CXT
Q4 25
2.23×
Q3 25
1.82×
Q2 25
1.45×
2.52×
Q1 25
-0.88×
Q4 24
Q3 24
1.42×
Q2 24
1.37×
Q1 24
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

CXT
CXT

Other$260.9M55%
Products$181.1M38%
Services$34.9M7%

Related Comparisons